(Total Views: 161)
Posted On: 12/14/2022 11:05:46 AM
Post# of 27138
$GNPX News Article - Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA in Combination with Tagrisso in Advanced Non-Small Cell Lung Cancer https://marketwirenews.com/news-releases/genp...21194.html
(0)
(0)
My Twitter: WhyteStocks
